Page last updated: 2024-12-07

chromium-51

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Chromium-51 is a radioactive isotope of chromium, a transition metal. It is used in nuclear medicine as a radioactive tracer, particularly for the diagnosis of gastrointestinal disorders. Chromium-51 is produced by bombarding a stable chromium isotope with neutrons in a nuclear reactor. Chromium-51 is used to study the absorption and metabolism of iron, the function of the spleen, and the blood volume. Chromium-51 is also used in diagnostic imaging of the gastrointestinal tract, where it can be used to track the movement of food through the digestive system. It is used in the study of gastrointestinal absorption and transit times, as well as in the diagnosis of malabsorption disorders. Chromium-51 has a half-life of 27.7 days and emits gamma rays. Chromium-51 is administered intravenously or orally, depending on the specific test being performed. It is important to note that Chromium-51 is radioactive and should be used only under the supervision of a qualified healthcare professional.'

chromium-51 : A synthetic radioactive isotope of chromium having a half-life of 27.7 days and decaying by electron capture with emission of gamma rays (0.32 MeV); it is used to label red blood cells for measurement of mass or volume, survival time, and sequestration studies, for the diagnosis of gastrointestinal bleeding, and to label platelets to study their survival. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID104786
CHEBI ID50076

Synonyms (26)

Synonym
14392-02-0
chromium, isotope of mass 51
(51)24cr
chromium-51
CHEBI:50076 ,
51cr
(51)cr
9qau17n705 ,
chromium cr-51
51cr radioisotope
chromium cr 51
unii-9qau17n705
cr-51 radioisotope
cr 51
chromium (51 cr) [who-dd]
chromium, cr-51
chromium (51 cr)
chromium 51
DB11140
(~51~cr)chromium
DTXSID90932164 ,
chromium, isotope ofmass 51
Q1973151
chromate(51 cr)
sodium chromate 51
dtxcid801360859
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Roles (1)

RoleDescription
radioactive labelnull
[role information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Drug Classes (1)

ClassDescription
chromium atomA chromium group element atom that has atomic number 24.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (20)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's9 (45.00)24.3611
2020's11 (55.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 46.22

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index46.22 (24.57)
Research Supply Index3.09 (2.92)
Research Growth Index4.68 (4.65)
Search Engine Demand Index66.83 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (46.22)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials1 (5.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other19 (95.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]